Neurogene Inc. short interest in 2025
In 2025, Neurogene Inc.'s disclosed short interest ran from 12.27% of shares outstanding on 15 Jan 2025 to 22.61% on 31 Dec 2025, a change of +10.34 percentage points. The year's high was 22.85% on 15 Dec 2025 and its low 11.79% on 14 Feb 2025, averaging 17.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.93 days on 29 Aug 2025. Full history: Neurogene Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 12.27% (15 Jan 2025)
- End of year
- 22.61% (31 Dec 2025)
- Change
- +10.34 pp
- High
- 22.85% (15 Dec 2025)
- Low
- 11.79% (14 Feb 2025)
- Average
- 17.69%
- Highest days to cover
- 28.93 (29 Aug 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 12.27% | 8.98 | |
| 31 Jan 2025 | 13.50% | 8.90 | |
| 14 Feb 2025 | 11.79% | 5.33 | |
| 28 Feb 2025 | 13.21% | 12.59 | |
| 14 Mar 2025 | 14.67% | 11.16 | |
| 31 Mar 2025 | 16.32% | 8.72 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 19.16% | 6.29 | |
| 30 Apr 2025 | 19.79% | 12.91 | |
| 15 May 2025 | 18.06% | 10.74 | 10-Q filed, results (8-K) |
| 30 May 2025 | 16.03% | 13.83 | |
| 13 Jun 2025 | 15.04% | 10.18 | |
| 30 Jun 2025 | 14.82% | 12.36 | |
| 15 Jul 2025 | 17.10% | 9.27 | |
| 31 Jul 2025 | 17.37% | 22.13 | |
| 15 Aug 2025 | 18.63% | 21.62 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 19.19% | 28.93 | |
| 15 Sep 2025 | 19.78% | 16.56 | |
| 30 Sep 2025 | 19.87% | 19.02 | |
| 15 Oct 2025 | 20.03% | 9.65 | |
| 31 Oct 2025 | 19.93% | 13.06 | |
| 14 Nov 2025 | 21.40% | 11.00 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 21.21% | 15.75 | |
| 15 Dec 2025 | 22.85% | 18.30 | |
| 31 Dec 2025 | 22.61% | 18.12 |
See also: Neurogene Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.